[
  {
    "ts": null,
    "headline": "Our Top 10 High Growth Dividend Stocks - July 2025",
    "summary": "We provide a methodology for selecting high-growth dividend-paying stocks. Click here to read more about the basis of the final list of ten stocks.",
    "url": "https://finnhub.io/api/news?id=527b222ccaf6815b1af546152af170a39250547c58e88b9ca4e9c3b7bf3d89ed",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752912000,
      "headline": "Our Top 10 High Growth Dividend Stocks - July 2025",
      "id": 136013218,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1177165160/image_1177165160.jpg?io=getty-c-w1536",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "We provide a methodology for selecting high-growth dividend-paying stocks. Click here to read more about the basis of the final list of ten stocks.",
      "url": "https://finnhub.io/api/news?id=527b222ccaf6815b1af546152af170a39250547c58e88b9ca4e9c3b7bf3d89ed"
    }
  },
  {
    "ts": null,
    "headline": "Why Gilead Sciences (GILD) Appeals to Income Investors in the Pharma Sector",
    "summary": "Gilead Sciences, Inc. (NASDAQ:GILD) is included among the 14 Best Pharma Dividend Stocks to Buy in 2025. The company rose to prominence during the COVID-19 pandemic thanks to its antiviral drug remdesivir, one of the earliest approved treatments for the virus. However, despite its scientific breakthroughs and commercial achievements, Gilead has lagged behind the broader […]",
    "url": "https://finnhub.io/api/news?id=65e28accb99c77092dc270ddeb43eba7aedcc707510fe14cd60c8d897de604e9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752888699,
      "headline": "Why Gilead Sciences (GILD) Appeals to Income Investors in the Pharma Sector",
      "id": 136012005,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Gilead Sciences, Inc. (NASDAQ:GILD) is included among the 14 Best Pharma Dividend Stocks to Buy in 2025. The company rose to prominence during the COVID-19 pandemic thanks to its antiviral drug remdesivir, one of the earliest approved treatments for the virus. However, despite its scientific breakthroughs and commercial achievements, Gilead has lagged behind the broader […]",
      "url": "https://finnhub.io/api/news?id=65e28accb99c77092dc270ddeb43eba7aedcc707510fe14cd60c8d897de604e9"
    }
  }
]